Therapy Areas: Vaccines
Blue Lake Biotechnology reports interim data from Phase 1/2a paediatric clinical trial of BLB201
13 October 2026 - Blue Lake Biotechnology Inc, a clinical-stage intranasal vaccine company, on Monday reported the presentation of interim data from the company's Phase 1/2a paediatric clinical t...
TETRAPHARM names new CEO
12 October 2026 - Danish biopharmaceutical company TETRAPHARM announced on Friday that it has appointed Rolf Sass Sorensen as its new chief executive officer.He succeeds Martin Rose, who founded the c...
Northwest Biotherapeutics and NHSBT collaborate to support production of DCVax-L
9 October 2026 - Northwest Biotherapeutics (NWBio) (OTCQB:NWBO), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Thursday a collaboration ...
Bavarian Nordic reports purchases under share buy-back programme
22 September 2026 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) on Monday published an update on its share buy-back programme launched on 1 September 2026, under which the company wi...
VaxThera partners with Codagenix for next generation yellow fever vaccine advancement
16 September 2026 - Colombian biotechnology company VaxThera S.A.S. and US-based Codagenix Inc, a clinical-stage biotechnology company focused on synthetic biology-based vaccines, announced on Tuesday...
PSMA Connect partners with HealthIQ Solutions
15 September 2026 - PSMA Connect, a Healthcare Group Purchasing Organisation (GPO), and HealthIQ Solutions, a provider of remote patient care management and clinical technology, said on Monday that th...